Carbamic acid, N-ethyl-, ethyl ester

117.15

117.15

210-812-9

P1WCG74L8I

440

DTXSID0060775

2924199090

38.3

1.14330

white

0.9813 g/cm³ @ Temp: 20 °C

60°C (estimate)

176 °C @ Press: 760 Torr

168 °F

n20/D 1.421(lit.)

SOL IN WATER; VERY SOL IN ALCOHOL, ETHER

1.44e-11 cm3/molecule*sec

3

40-36/37/38

36/37/39-26-36/37

FA9100000

Xn,Xi

P201, P202, P261, P264, P271, P280, P281, P302+P352, P304+P340, P305+P351+P338, P308+P313, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, P501

H315

|Warning|H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]|P201, P202, P261, P264, P271, P280, P281, P302+P352, P304+P340, P305+P351+P338, P308+P313, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501|Aggregated GHS information provided by 38 companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

THE TUMOR INITIATING POTENCY OF ETHYL CARBAMATE HOMOLOGS & ETHYL CARBAMATE N-SUBSTITUTED DERIVATIVES WERE STUDIED AFTER SUBCUTANEOUS INJECTION INTO MICE FOLLOWED BY TREATMENT WITH THE PROMOTER CROTON OIL. THE TUMOR INITIATING POTENCIES WERE, IN DESCENDING ORDER ETHYL CARBAMATE, ETHYL N-METHYLCARBAMATE, ETHYL N-ETHYLCARBAMATE, & BUTYL CARBAMATE.

EXPTL USE: N-ETHYLURETHAN HAD NO THROMBOLYTIC EFFECT ON HUMAN BLOOD FLOWING IN A CLOSED ROTATING LOOP OF PLASTIC TUBING BUT IT GREATLY ENHANCED THE EFFECTS OF UROKINASE & STREPTOKINASE.

Carbamic acid, N-ethyl-, ethyl ester: INACTIVE